10,451 Results

Looking for alternatives

 Added 1 day ago

Looking for alternatives

Phase III SENSCIS trial of Vargatef shows efficacy in interstitial lung disease

 Added 1 day ago

Boehringer announced that the phase III SENSCIS trial of Vargatef (nintedanib) met its primary endpoint: reduction in the annual rate...

Phase III fliGHt trial shows TransCon Growth Hormone safe in pediatric growth hormone deficiency

 Added 1 day ago

Ascendis Pharma announced preliminary results from the phase III fliGHt Trial of TransCon Growth Hormone (hGH). The results indicated treatment...

Post-hoc analysis of GRIPHON study for Uptravi

 Added 1 day ago

Actelion Pharmaceuticals has presented results of a post-hoc exploratory analysis of the GRIPHON study in patients with pulmonary arterial hypertension...

FDA approves Nayzilam for epilepsy

 Added 1 day ago

UCB announced that the FDA has approved a New Drug Application for the company's newest anti-epileptic drug (AED) Nayzilam (midazolam)...

Pivotal phase III trial of Yupelri shows additional control of COPD

 Added 1 day ago

Theravance Biopharma and Mylan announced the presentation of data from its pivotal Phase III efficacy studies and a 52-week safety...

Cirrhosis related deaths expected to treble by 2030

 Added 1 day ago

Results presented at Digestive Disease Week® (DDW) 2019 have suggested there are identifiable and modifiable risk factors that might prevent liver disease, which should be the subject of further research.

Researchers document impact of coffee on bowels

 Added 1 day ago

One of the more light-hearted studies presented this week at Digestive Disease Week® (DDW) 2019 suggested that caffeine may not be behind increased bowel movements in coffee drinkers.

Button batteries can rapidly damage stomach lining before symptoms appear

 Added 1 day ago

Research presented this week at Digestive Disease Week® (DDW) 2019 suggested that clinicians must act fast in the event of a child ingesting a button battery.

MTB-RIF/INH test is used to detect antibiotic resistance mutations in the Mycobacterium tuberculosis

 Added 3 days ago

Roche secured the CE-IVD mark for its Cobas MTB-RIF/INH test, an assay used to detect antibiotic resistance mutations in the...

Load more